Oxidative Stress in Traumatic Brain Injury

Area of Science:

• Neuroscience
• Biochemistry
• Pathophysiology

Background:

• Traumatic Brain Injury (TBI) is a leading cause of global disability.
• TBI triggers a complex neurometabolic cascade involving oxidative stress.
• Oxidative stress in TBI involves reactive oxygen species (ROS) and reactive nitrogen species (RNS), leading to secondary injury.

Purpose of the Study:

• To examine the pathophysiological mechanisms of TBI, focusing on oxidative stress.
• To review current and potential antioxidant therapies for TBI.
• To highlight challenges and benefits of antioxidant treatments for TBI.

Main Methods:

• Review of existing literature on TBI pathophysiology and antioxidant therapies.
• Analysis of mechanisms involving ROS, RNS, and lipid peroxidation.
• Evaluation of clinical studies on antioxidant interventions for TBI.

Main Results:

• Antioxidant therapies, including free radical scavengers and enzyme modulators, have demonstrated cognitive and functional recovery in TBI patients.
• These therapies exhibit minimal side effects and ease of clinical application.
• Lipid peroxidation products contribute to chronic inflammation and synaptic dysfunction post-TBI.

Conclusions:

• Antioxidant therapies represent a promising treatment avenue for TBI, despite the lack of FDA-approved options.
• Addressing the heterogeneous nature of TBI and ensuring timely treatment are key challenges.
• Further research into studied antioxidant regimens could facilitate clinical application for TBI recovery.